Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Roupret

Showing results (171-180 of 273) with videos related to

Pageof 28
Sort By:
BJU International|August 4, 2020
Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric studyPaulo Gontero, Emanuele Montanari, Morgan Roupret, et al.
European Urology Oncology|October 25, 2024
Regional Versus Systematic Biopsy in Addition to Targeted Biopsy: Results from a Systematic Review and Meta-analysisFrancesco Sanguedolce, Carol Nelly Gianna Lauwers, Alessandro Tedde, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical CystectomyMarco Moschini, Francesco Soria, Martin Susani, et al.
BMJ Surgery, Interventions, & Health Technologies|March 5, 2025
Hidden costs of surgical complications: a retrospective cohort studyFrançois-Xavier Ladant, Yann Parc, Morgan Roupret, et al.
The Journal of Urology|April 22, 2020
Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European StudyMorgan Roupret, Paolo Gontero, Stuart R C McCracken, et al.
BJU International|May 15, 2014
Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre studyGéraldine Pignot, Laurent Salomon, Cédric Lebacle, et al.
BJU International|September 24, 2017
Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma CollaborationAndrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
European Urology Focus|April 18, 2018
Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological UrologyRiccardo Campi, Sabine D Brookman-May, Jose Daniel Subiela Henríquez, et al.
World Journal of Urology|June 20, 2022
Partial nephrectomy in solitary kidneys: comparison between open surgery and robotic-assisted laparoscopy on perioperative and functional outcomes (UroCCR-54 study)Ygal Benichou, François Audenet, Karim Bensalah, et al.
Clinical Genitourinary Cancer|March 31, 2019
Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 PatientsGuillaume Klausner, Idriss Troussier, Julian Biau, et al.
Pageof 28

Showing results (171-180 of 273) with videos related to

Sort By:
Pageof 28
BJU International|August 4, 2020
Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric studyPaulo Gontero, Emanuele Montanari, Morgan Roupret, et al.
European Urology Oncology|October 25, 2024
Regional Versus Systematic Biopsy in Addition to Targeted Biopsy: Results from a Systematic Review and Meta-analysisFrancesco Sanguedolce, Carol Nelly Gianna Lauwers, Alessandro Tedde, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical CystectomyMarco Moschini, Francesco Soria, Martin Susani, et al.
BMJ Surgery, Interventions, & Health Technologies|March 5, 2025
Hidden costs of surgical complications: a retrospective cohort studyFrançois-Xavier Ladant, Yann Parc, Morgan Roupret, et al.
The Journal of Urology|April 22, 2020
Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European StudyMorgan Roupret, Paolo Gontero, Stuart R C McCracken, et al.
BJU International|May 15, 2014
Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre studyGéraldine Pignot, Laurent Salomon, Cédric Lebacle, et al.
BJU International|September 24, 2017
Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma CollaborationAndrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
European Urology Focus|April 18, 2018
Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological UrologyRiccardo Campi, Sabine D Brookman-May, Jose Daniel Subiela Henríquez, et al.
World Journal of Urology|June 20, 2022
Partial nephrectomy in solitary kidneys: comparison between open surgery and robotic-assisted laparoscopy on perioperative and functional outcomes (UroCCR-54 study)Ygal Benichou, François Audenet, Karim Bensalah, et al.
Clinical Genitourinary Cancer|March 31, 2019
Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 PatientsGuillaume Klausner, Idriss Troussier, Julian Biau, et al.
Pageof 28